Regeneron Reports IDMC Clearance of Efficacy for REGEN-COV (Casirivimab + Imdevimab) in P-III COVID-19 Outpatient Outcomes Trial

Published: Feb 26, 2021 | Tags: Regeneron, Reports, IDMC, Clearance, Efficacy, REGEN-COV (Casirivimab + Imdevimab), P-III, COVID-19, Outpatient, Outcomes, Trial

Daiichi Sankyo Collaborates with LYSA-LYSARC-CALYM for Valemetostat in Patients with R/R B-Cell Lymphoma

Published: Feb 26, 2021 | Tags: Daiichi Sankyo, Collaborates, LYSA-LYSARC-CALYM, Valemetostat,  Patients, R/R B-Cell Lymphoma

Lilly to Integrate its Digital Insulin Pen with Welldoc's BlueStar App

Published: Feb 26, 2021 | Tags: Lilly, Integrate, Digital Insulin Pen, Welldoc, BlueStar App

GSK Report Results of Otilimab in P-II OSCAR Study to Treat Hospitalized Patients with COVID-19

Published: Feb 26, 2021 | Tags: GSK, Report, Results, Otilimab, P-II, OSCAR Study, Treat, Hospitalized Patients, COVID-19

Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

Published: Feb 26, 2021 | Tags: Otsuka and Click, Initiate, Digital, Study, Adults, Major, Depressive Disorder

Merck to Acquire Pandion for ~$1.85B

Published: Feb 26, 2021 | Tags: Merck, Acquire, Pandion, ~$1.85B

Intra-Cellular Reports the Expansion of Pipeline with the Addition of ITI-1284

Published: Feb 25, 2021 | Tags: Intra-Cellular, Reports, Expansion, Pipeline, Addition, ITI-1284

Qiagen Expand its Collaboration with Inovio to Develop Liquid Biopsy Based CDx for VGX-3100 to Treat Advanced Cervical Dysplasia

Published: Feb 25, 2021 | Tags: Qiagen, Expand, Collaboration, Inovio, Develop, Liquid Biopsy, Based CDx, VGX-3100, Treat, Advanced, Cervical Dysplasia

AbbVie's Humira (adalimumab) Receives the US FDA's Approval to Treat Pediatric Patients with Ulcerative Colitis

Published: Feb 25, 2021 | Tags: AbbVie, Humira (adalimumab), Receives, US, FDA, Approval, Treat, Pediatric, Patients, Ulcerative Colitis

Roche Report Results of Evrysdi (risdiplam) in FIREFISH Study for Infants with Type 1 SMA

Published: Feb 25, 2021 | Tags: Roche, Report, Results, Evrysdi (risdiplam), FIREFISH, Study, Infant, Type 1 SMA

Sanofi Collaborates with Sirion to Develop Gene Therapy Treatment with Improved AAV Capsids

Published: Feb 25, 2021 | Tags: Sanofi, Collaborates, Sirion, Develop, Gene Therapy, Treatment,  Improved, AAV Capsids

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

Published: Feb 25, 2021 | Tags: UCB, Collaborates, Microsoft, Accelerate, Drug, Discovery, Development

Bio-Techne Collaborates with Luminary to Utilize TcBuster in the Development of CAR-T cell Therapies

Published: Feb 24, 2021 | Tags: Bio-Techne, Collaborates, Luminary, Utilize, TcBuster, Development, CAR-T cell, Therapies

Takeda Reports First Patients Dosing in P-I/II Study of Novavax's COVID-19 Vaccine Candidate in Japan

Published: Feb 24, 2021 | Tags: Takeda, Reports, First, Patients, Dosing, P-I/II, Study, Novavax, COVID-19, Vaccine Candidate, Japan

Pfizer Reports the US FDA's Acceptance and Priority Review of BLA for Ticovac (Tick-Borne Encephalitis Vaccine)

Published: Feb 24, 2021 | Tags: Pfizer, Reports, US, FDA, Acceptance, Priority Review, BLA, Ticovac (Tick-Borne Encephalitis Vaccine)

Merck KGaA Signs an Exclusive Worldwide License Agreement with Day One for Pimasertib and MSC2015103B

Published: Feb 24, 2021 | Tags: Merck, KGaA, Signs, Exclusive, Worldwide, License, Agreement, Day One, Pimasertib, MSC2015103B

Sanofi's Dupixent (dupilumab) Receives Health Canada Approval as the First Biologic to Treat Atopic Dermatitis in Children

Published: Feb 24, 2021 | Tags: Sanofi, Dupixent (dupilumab), Receives, Health Canada, Approval, First, Biologic, Treat, Atopic Dermatitis, Children

Graviton Signs an Exclusive Worldwide License Agreement with Beijing Tide for TDI01

Published: Feb 24, 2021 | Tags: Graviton, Signs, Exclusive, Worldwide, License, Agreement, Beijing Tide, TDI01

MatriSys Report Results of MSB-0221 in P-I study for the Topical Treatment of Atopic Dermatitis

Published: Feb 23, 2021 | Tags: MatriSys, Report, Results, MSB-0221, P-I study, Topical, Treatment, Atopic Dermatitis

Amgen Reports sNDA Submission of Otezla (apremilast) to The US FDA's for Adults with Mild to Moderate Plaque Psoriasis

Published: Feb 23, 2021 | Tags: Amgen, Reports, sNDA, Submission, Otezla (apremilast), US, FDA, Adults, Mild, Moderate, Plaque Psoriasis

BMS Expands its Collaboration with Compugen to Evaluate the Combination of COM701 + Opdivo

Published: Feb 23, 2021 | Tags: BMS, Expands, Collaboration, Compugen, Evaluate, Combination,  COM701 + Opdivo

Incyte Reports the US FDA's Acceptance of sNDA for Priority Review of Jakafi (ruxolitinib) to Treat Chronic Graft Versus Host Disease

Published: Feb 23, 2021 | Tags: Incyte, Reports, US, FDA, Acceptance, sNDA, Priority Review, Jakafi (ruxolitinib), Treat, Chronic, Graft, Versus, Host Disease

AbbVie Report Results of Rinvoq (upadacitinib) in Second P-III Induction Study for Ulcerative Colitis

Published: Feb 23, 2021 | Tags: AbbVie, Report, Results, Rinvoq (upadacitinib), Second, P-III, Induction Study, Ulcerative Colitis

Regeneron and Sanofi's Libtayo (cemiplimab-rwlc) Receive the US FDA's Approval as 1L Treatment for Advanced NSCLC

Published: Feb 23, 2021 | Tags: Regeneron and Sanofi, Libtayo (cemiplimab-rwlc), Receive, US, FDA, Approval, 1L, Treatment, Advanced, NSCLC

Sanofi and GSK Initiate P-II Study of their Adjuvanted Recombinant Protein-Based COVID-19 Vaccine

Published: Feb 22, 2021 | Tags: Sanofi and GSK, Initiate, P-II, Study, Adjuvanted, Recombinant Protein-Based, COVID-19, Vaccine

AstraZeneca to Withdraw Imfinzi Indication in Advanced Bladder Cancer in the US

Published: Feb 22, 2021 | Tags: AstraZeneca, Withdraw, Imfinzi, Indication, Advanced, Bladder Cancer, US

Incyte Reports the US FDA's Acceptance of NDA for Priority Review of Ruxolitinib Cream to Treat Atopic Dermatitis

Published: Feb 22, 2021 | Tags: Incyte, Reports, US, FDA, Acceptance, NDA, Priority Review, Ruxolitinib Cream, Treat, Atopic Dermatitis

Astellas Reports Results of Fezolinetant in Two P-III Studies for the Nonhormonal Treatment of VMS in Postmenopausal Women

Published: Feb 22, 2021 | Tags: Astellas, Reports, Results, Fezolinetant, Two, P-III, Studies, Nonhormonal, Treatment, VMS, Postmenopausal, Women

Immunocore's Tebentafusp Receives the US FDA's Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma

Published: Feb 22, 2021 | Tags: Immunocore, Tebentafusp, Receives, US, FDA Breakthrough, Therapy, Designation, Unresectable, Metastatic, Uveal Melanoma

Roche Concludes the License Agreement with Chugai for AT-527 to Treat COVID-19 in Japan

Published: Feb 22, 2021 | Tags: Roche, Concludes, License, Agreement, Chugai, AT-527, Treat, COVID-19, Japan

Related post: PharmaShots Weekly Snapshots (Feb 15- 19, 2021)